CTI BioPharma (CTI BioPharma) Days Inventory : 56.29 (As of Mar. 2023)

View and export this data going back to 1997. Start your Free Trial

What is CTI BioPharma Days Inventory?

Days Inventory is also known as Days Sales of Inventory (DSI). CTI BioPharma's Average Total Inventories for the three months ended in Mar. 2023 was $0.76 Mil. CTI BioPharma's Cost of Goods Sold for the three months ended in Mar. 2023 was $1.22 Mil. Hence, CTI BioPharma's Days Inventory for the three months ended in Mar. 2023 was 56.29.

The historical rank and industry rank for CTI BioPharma's Days Inventory or its related term are showing as below:

CTIC' s Days Inventory Range Over the Past 10 Years
Min: 56.65 Med: 1095.12 Max: 8925.18
Current: 56.65

During the past 13 years, CTI BioPharma's highest Days Inventory was 8925.18. The lowest was 56.65. And the median was 1095.12.

CTIC's Days Inventory is not ranked
in the Biotechnology industry.
Industry Median: 191.14 vs CTIC: 56.65

CTI BioPharma's Days Inventory increased from Mar. 2022 (33.48) to Mar. 2023 (56.29). It might indicate that CTI BioPharma's sales slowed down.

Warning Sign:

If a company builds up inventory, it may mean it is having difficulties selling its goods.

Inventory Turnover measures how fast the company turns over its inventory within a year. CTI BioPharma's Inventory Turnover for the three months ended in Mar. 2023 was 1.62.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. CTI BioPharma's Inventory-to-Revenue for the three months ended in Mar. 2023 was 0.03.

CTI BioPharma Days Inventory Historical Data

The historical data trend for CTI BioPharma's Days Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CTI BioPharma Days Inventory Chart

CTI BioPharma Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Days Inventory

Get a 7-Day Free Trial

76.14

CTI BioPharma Quarterly Data
	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23
Days Inventory	Get a 7-Day Free Trial															33.48	40.00	73.23	73.50	56.29

Competitive Comparison of CTI BioPharma's Days Inventory

For the Biotechnology subindustry, CTI BioPharma's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

CTI BioPharma's Days Inventory Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, CTI BioPharma's Days Inventory distribution charts can be found below:

* The bar in red indicates where CTI BioPharma's Days Inventory falls into.

CTI BioPharma Days Inventory Calculation

Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

CTI BioPharma's Days Inventory for the fiscal year that ended in Dec. 2022 is calculated as

	Days Inventory (A: Dec. 2022 )
=	Average Total Inventories					/	Cost of Goods Sold	*	Days in Period
=	( (Total Inventories (A: Dec. 2021 )	+	Total Inventories (A: Dec. 2022 ))	/	count )	/	Cost of Goods Sold (A: Dec. 2022 )	*	Days in Period
=	( (0	+	0.733)	/	1 )	/	3.514	*	365
=	0.733					/	3.514	*	365
=	76.14

CTI BioPharma's Days Inventory for the quarter that ended in Mar. 2023 is calculated as:

	Days Inventory (Q: Mar. 2023 )
=	Average Total Inventories					/	Cost of Goods Sold	*	Days in Period
=	( (Total Inventories (Q: Dec. 2022 )	+	Total Inventories (Q: Mar. 2023 ))	/	count )	/	Cost of Goods Sold (Q: Mar. 2023 )	*	Days in Period
=	( (0.733	+	0.777)	/	2 )	/	1.224	*	365 / 4
=	0.755					/	1.224	*	365 / 4
=	56.29

CTI BioPharma (NAS:CTIC) Days Inventory Explanation

Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:

1. Inventory Turnover measures how fast the company turns over its inventory within a year.

CTI BioPharma's Inventory Turnover for the three months ended in Mar. 2023 is calculated as

Inventory Turnover	=	Cost of Goods Sold	/	Average Total Inventories
	=	1.224	/	0.755
	=	1.62

2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

CTI BioPharma's Inventory to Revenue for the three months ended in Mar. 2023 is calculated as

Inventory-to-Revenue	=	Average Total Inventories	/	Revenue
	=	0.755	/	24.116
	=	0.03

Be Aware

A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.

CTI BioPharma Days Inventory Related Terms

Thank you for viewing the detailed overview of CTI BioPharma's Days Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.

CTI BioPharma (CTI BioPharma) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CTI BioPharma Corp (NAS:CTIC) » Definitions » Days Inventory

Comparable Companies

Traded in Other Exchanges

N/A

Address

3101 Western Avenue, Suite 800, Seattle, WA, USA, 98121

Website

https://www.ctibiopharma.com

CTI BioPharma Corp is a biopharmaceutical company focused on the acquisition, development, and commercialization of less toxic and more effective cancer therapies. Its therapeutic area is blood-related cancers. Its products under the pipeline include Pacritinib. Pacritinib is an investigational oral kinase inhibitor for the treatment of adult patients with myelofibrosis.

Executives

James K Fong	officer: EVP & Chief Commercial Officer	C/O CTI BIOPHARMA CORP, 3101 WESTERN AVENUE, SUITE 800, SEATTLE WA 98121
Adam R Craig	director, officer: President and CEO	C/O INNOVIVE PHARMACEUTICALS, INC., 555 MADISON AVENUE, 25TH FLOOR, NEW YORK NY 10022
David Kirske	officer: EVP, Chief Financial Officer	C/O CTI BIOPHARMA CORP., 3101 WESTERN AVE., SUITE 600, SEATTLE WA 98121
Michael A Metzger	director	C/O SYNDAX PHARMACEUTICALS, INC., 400 TOTTEN POND ROAD,, WALTHAM MA 02451
Biotechnology Value Fund L P	other: See Explanation of Responses	44 MONTGOMERY STREET, 40TH FL, SAN FRANCISCO CA 94104
Diane L. Parks	director	29 EMMONS DRIVE, SUITE B-10, PRINCETON NJ 08540
Matthew D Perry	director	ONE SANSOME STREET, 30TH FLOOR, SAN FRANCISCO CA 94104
Orbimed Advisors Llc	10 percent owner	601 LEXINGTON AVENUE, 54TH FLOOR, NEW YORK NY 10022
Bvf I Gp Llc	10 percent owner	44 MONTGOMERY ST., 40TH FLOOR, SAN FRANCISCO CA 94104
Bvf Gp Holdings Llc	10 percent owner	44 MONTGOMERY ST., 40TH FLOOR, SAN FRANCISCO CA 94104
Bvf Ii Gp Llc	other: See Explanation of Responses	44 MONTGOMERY ST., 40TH FLOOR, SAN FRANCISCO CA 94104
Laurent Fischer	director	C/O ADVERUM BIOTECHNOLOGIES, INC., 100 CARDINAL WAY, REDWOOD CITY CA 94063
David Ross Parkinson	director	C/O THRESHOLD PHARMACEUTICALS, INC., 170 HARBOR WAY SUITE 300, SOUTH SAN FRANCISCO CA 94080
Richard L Love	director
Biotechnology Value Fund Ii Lp	other: See Explanation of Responses	44 MONTGOMERY STREET, 40TH FL, SAN FRANCISCO CA 94104